Description
N/A
Screenshots
Loading...
Please wait..
SilhouetteLite+ FAQ
-
Is SilhouetteLite+ free?
Yes, SilhouetteLite+ is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is SilhouetteLite+ legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does SilhouetteLite+ cost?
SilhouetteLite+ is free.
-
What is SilhouetteLite+ revenue?
To get estimated revenue of SilhouetteLite+ app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in South Korea yet.
Ratings History
SilhouetteLite+ Reviews
No Reviews in South Korea
App doesn't have any reviews in South Korea yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
SilhouetteLite+ Installs
Last 30 days
SilhouetteLite+ Revenue
Last 30 daysSilhouetteLite+ Revenue and Downloads
Gain valuable insights into SilhouetteLite+ performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- ARANZ Medical
- Languages
- English
- Recent release
- 1.13 (1 year ago )
- Released on
- Nov 21, 2017 (7 years ago )
- Also available in
- United States , New Zealand , Poland , India , Italy , Japan , South Korea , Kuwait , Lebanon , Mexico , Nigeria , Netherlands , Norway , Peru , Philippines , Pakistan , Israel , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.